J — Lotus Ventures Cashflow Statement
0.000.00%
HealthcareSpeculativeMicro Cap
Annual cashflow statement for Lotus Ventures, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | Interim Report |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.91 | 1.49 | 0.241 | -4.79 | -1.87 |
| Depreciation | |||||
| Non-Cash Items | 0.732 | -0.629 | -0.079 | 3.44 | 0.962 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.52 | -1.4 | 0.037 | -0.423 | -0.795 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.31 | 0.205 | 0.909 | -1.11 | -1.08 |
| Capital Expenditures | -7.27 | -0.654 | -0.607 | -0.059 | -0.107 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -7.27 | -0.654 | -0.607 | -0.059 | -0.107 |
| Financing Cash Flow Items | 1.12 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.95 | 0.621 | -0.005 | 0.639 | 1.19 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.63 | 0.172 | 0.297 | -0.533 | -0.002 |